Mable

First personalized migraine clinic using genetics and telehealth.

Y CombinatorSummer 2021AcquiredHealthcareMedical DevicesHealth TechTelehealthGenomics

What they do

Problem

Migraine patients struggle to find effective medications and ongoing specialist care that is tailored to their biology.

Solution

A telehealth migraine clinic that uses genetic testing to personalize medication selection and provides continuous expert care.

Who it's for

Individuals suffering from migraines seeking personalized treatment and ongoing remote care.

Founders

Roman Rothaermel

Founder

Roman is a neuroscientist who has conducted several years of research on memory encoding in the brain, neuropharmacology and drug target characterization. During his PhD at Oxford University he uncovered a new mechanism causing brain-wide synchronization which is necessary for correct retrieval of complex memories. He also has an MSc in Neuroscience (Oxford, UK) and MSc in Biology (Tubingen, Germany).

Inna Thalmann

Founder

Inna is Co-Founder and COO of Mable - a precision medicine company using whole genome sequencing to optimise prescribing decisions. Prior to this, Inna completed her PhD in Econometrics with a focus on Health Economics at the University of Oxford, followed by postdoctoral research focused on the development of novel phenotype algorithms to increase the cost-efficiency of clinical trials.